In contrast those losing weight through diet and exercise alone only saw a reduction of 3% over that time period, the same study found
Dosing Regimens and Administration Logistics Both peptides support subcutaneous application once a week, which makes it easier for patients to follow through and makes injections less painful than daily options
The key findings included failure to use proper equipment, failure to adequately vet suppliers, and failure to thoroughly assess the risks associated with injectable drug products
Patients with pre-existing diabetic retinopathy should be monitored for worsening retinopathy during rapid improvement in glycemic control
Foundayo (orforglipron), a contemporary oral GLP-1 option, can be consumed anytime without meal or drink restrictions offering extensive flexibility
However, some have reported nausea, vomiting, diarrhea, stomach pain, or constipation